Effect of somatostatin-induced insulinopenia on glucose oxidation in man

J. P. Felber, D. Thiébaud, E. Maeder, E. Jéquier, R. Hendler, Ralph A Defronzo

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

In the basal state the body utilizes glucose at a rate of 2.2-2.3 mg· kg-1·min-1; of this approximately 1.2-1.3 mg · kg-1 · min-1 is oxidized, while the remaining 1.0 mg · kg-1·min-1 must be utilized by non-oxidative pathways. Little information is, however, available concerning the insulin dependency of these processes. To examine the role of basal insulin levels on glucose oxidation, glucose storage and total body glucose uptake, somatostatin (10 μg/min) was infused for 2 h in nine volunteers while maintaining plasma glucose concentration constant at basal levels by an exogenous glucose infusion. Basal plasma insulin fell by about 50% (13±2 to 7±1mU/l, p<0.01). Total body glucose metabolism (3H-3-glucose) declined from 2.3±0.1 to 1.9±0.1mg· kg-1·min-1 (p<0.01). This decrease was entirely accounted for by a fall in basal glucose oxidation (measured by indirect calorimetry) from 1.3±0.1 to 0.7±0.1 mg·kg-1·min-1 (p< 0.001). To assess the specific role of insulin deficiency in the decline in glucose oxidation, subjects were restudied with somatostatin plus basal insulin replacement (0.07 mg ·kg-1· min-1). Fasting insulin concentration (14±1 mU/1) remained constant during somatostatin plus insulin infusion (13±1mU/l) and basal rates of glucose oxidation (1.2±0.1 mg · kg-1·min-1) and total body glucose uptake did not change significantly. After 2 h, the basal insulin infusion was stopped and somatostatin was continued. Over the subsequent hour, glucose oxidation declined by 0.4±0.1 mg· kg-1 · min-1. This decrease was associated with a parallel decrease in total body glucose uptake of 0.4±0.1 mg·kg-1 ·min-1. These results indicate that approximately 50% of basal glucose oxidation is dependent upon basal insulin secretion. Non-oxidative pathways of glucose metabolism under basal conditions appear to be insulin independent.

Original languageEnglish (US)
Pages (from-to)325-330
Number of pages6
JournalDiabetologia
Volume25
Issue number4
DOIs
StatePublished - Oct 1983
Externally publishedYes

Fingerprint

Somatostatin
Glucose
Insulin
Basal Metabolism
Indirect Calorimetry
Volunteers
Fasting

Keywords

  • glucose oxidation
  • indirect calorimetry
  • insulin deficiency
  • Somatostatin

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Felber, J. P., Thiébaud, D., Maeder, E., Jéquier, E., Hendler, R., & Defronzo, R. A. (1983). Effect of somatostatin-induced insulinopenia on glucose oxidation in man. Diabetologia, 25(4), 325-330. https://doi.org/10.1007/BF00253195

Effect of somatostatin-induced insulinopenia on glucose oxidation in man. / Felber, J. P.; Thiébaud, D.; Maeder, E.; Jéquier, E.; Hendler, R.; Defronzo, Ralph A.

In: Diabetologia, Vol. 25, No. 4, 10.1983, p. 325-330.

Research output: Contribution to journalArticle

Felber, JP, Thiébaud, D, Maeder, E, Jéquier, E, Hendler, R & Defronzo, RA 1983, 'Effect of somatostatin-induced insulinopenia on glucose oxidation in man', Diabetologia, vol. 25, no. 4, pp. 325-330. https://doi.org/10.1007/BF00253195
Felber, J. P. ; Thiébaud, D. ; Maeder, E. ; Jéquier, E. ; Hendler, R. ; Defronzo, Ralph A. / Effect of somatostatin-induced insulinopenia on glucose oxidation in man. In: Diabetologia. 1983 ; Vol. 25, No. 4. pp. 325-330.
@article{31364913a6dd4862a840d83897d8cc8d,
title = "Effect of somatostatin-induced insulinopenia on glucose oxidation in man",
abstract = "In the basal state the body utilizes glucose at a rate of 2.2-2.3 mg· kg-1·min-1; of this approximately 1.2-1.3 mg · kg-1 · min-1 is oxidized, while the remaining 1.0 mg · kg-1·min-1 must be utilized by non-oxidative pathways. Little information is, however, available concerning the insulin dependency of these processes. To examine the role of basal insulin levels on glucose oxidation, glucose storage and total body glucose uptake, somatostatin (10 μg/min) was infused for 2 h in nine volunteers while maintaining plasma glucose concentration constant at basal levels by an exogenous glucose infusion. Basal plasma insulin fell by about 50{\%} (13±2 to 7±1mU/l, p<0.01). Total body glucose metabolism (3H-3-glucose) declined from 2.3±0.1 to 1.9±0.1mg· kg-1·min-1 (p<0.01). This decrease was entirely accounted for by a fall in basal glucose oxidation (measured by indirect calorimetry) from 1.3±0.1 to 0.7±0.1 mg·kg-1·min-1 (p< 0.001). To assess the specific role of insulin deficiency in the decline in glucose oxidation, subjects were restudied with somatostatin plus basal insulin replacement (0.07 mg ·kg-1· min-1). Fasting insulin concentration (14±1 mU/1) remained constant during somatostatin plus insulin infusion (13±1mU/l) and basal rates of glucose oxidation (1.2±0.1 mg · kg-1·min-1) and total body glucose uptake did not change significantly. After 2 h, the basal insulin infusion was stopped and somatostatin was continued. Over the subsequent hour, glucose oxidation declined by 0.4±0.1 mg· kg-1 · min-1. This decrease was associated with a parallel decrease in total body glucose uptake of 0.4±0.1 mg·kg-1 ·min-1. These results indicate that approximately 50{\%} of basal glucose oxidation is dependent upon basal insulin secretion. Non-oxidative pathways of glucose metabolism under basal conditions appear to be insulin independent.",
keywords = "glucose oxidation, indirect calorimetry, insulin deficiency, Somatostatin",
author = "Felber, {J. P.} and D. Thi{\'e}baud and E. Maeder and E. J{\'e}quier and R. Hendler and Defronzo, {Ralph A}",
year = "1983",
month = "10",
doi = "10.1007/BF00253195",
language = "English (US)",
volume = "25",
pages = "325--330",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Effect of somatostatin-induced insulinopenia on glucose oxidation in man

AU - Felber, J. P.

AU - Thiébaud, D.

AU - Maeder, E.

AU - Jéquier, E.

AU - Hendler, R.

AU - Defronzo, Ralph A

PY - 1983/10

Y1 - 1983/10

N2 - In the basal state the body utilizes glucose at a rate of 2.2-2.3 mg· kg-1·min-1; of this approximately 1.2-1.3 mg · kg-1 · min-1 is oxidized, while the remaining 1.0 mg · kg-1·min-1 must be utilized by non-oxidative pathways. Little information is, however, available concerning the insulin dependency of these processes. To examine the role of basal insulin levels on glucose oxidation, glucose storage and total body glucose uptake, somatostatin (10 μg/min) was infused for 2 h in nine volunteers while maintaining plasma glucose concentration constant at basal levels by an exogenous glucose infusion. Basal plasma insulin fell by about 50% (13±2 to 7±1mU/l, p<0.01). Total body glucose metabolism (3H-3-glucose) declined from 2.3±0.1 to 1.9±0.1mg· kg-1·min-1 (p<0.01). This decrease was entirely accounted for by a fall in basal glucose oxidation (measured by indirect calorimetry) from 1.3±0.1 to 0.7±0.1 mg·kg-1·min-1 (p< 0.001). To assess the specific role of insulin deficiency in the decline in glucose oxidation, subjects were restudied with somatostatin plus basal insulin replacement (0.07 mg ·kg-1· min-1). Fasting insulin concentration (14±1 mU/1) remained constant during somatostatin plus insulin infusion (13±1mU/l) and basal rates of glucose oxidation (1.2±0.1 mg · kg-1·min-1) and total body glucose uptake did not change significantly. After 2 h, the basal insulin infusion was stopped and somatostatin was continued. Over the subsequent hour, glucose oxidation declined by 0.4±0.1 mg· kg-1 · min-1. This decrease was associated with a parallel decrease in total body glucose uptake of 0.4±0.1 mg·kg-1 ·min-1. These results indicate that approximately 50% of basal glucose oxidation is dependent upon basal insulin secretion. Non-oxidative pathways of glucose metabolism under basal conditions appear to be insulin independent.

AB - In the basal state the body utilizes glucose at a rate of 2.2-2.3 mg· kg-1·min-1; of this approximately 1.2-1.3 mg · kg-1 · min-1 is oxidized, while the remaining 1.0 mg · kg-1·min-1 must be utilized by non-oxidative pathways. Little information is, however, available concerning the insulin dependency of these processes. To examine the role of basal insulin levels on glucose oxidation, glucose storage and total body glucose uptake, somatostatin (10 μg/min) was infused for 2 h in nine volunteers while maintaining plasma glucose concentration constant at basal levels by an exogenous glucose infusion. Basal plasma insulin fell by about 50% (13±2 to 7±1mU/l, p<0.01). Total body glucose metabolism (3H-3-glucose) declined from 2.3±0.1 to 1.9±0.1mg· kg-1·min-1 (p<0.01). This decrease was entirely accounted for by a fall in basal glucose oxidation (measured by indirect calorimetry) from 1.3±0.1 to 0.7±0.1 mg·kg-1·min-1 (p< 0.001). To assess the specific role of insulin deficiency in the decline in glucose oxidation, subjects were restudied with somatostatin plus basal insulin replacement (0.07 mg ·kg-1· min-1). Fasting insulin concentration (14±1 mU/1) remained constant during somatostatin plus insulin infusion (13±1mU/l) and basal rates of glucose oxidation (1.2±0.1 mg · kg-1·min-1) and total body glucose uptake did not change significantly. After 2 h, the basal insulin infusion was stopped and somatostatin was continued. Over the subsequent hour, glucose oxidation declined by 0.4±0.1 mg· kg-1 · min-1. This decrease was associated with a parallel decrease in total body glucose uptake of 0.4±0.1 mg·kg-1 ·min-1. These results indicate that approximately 50% of basal glucose oxidation is dependent upon basal insulin secretion. Non-oxidative pathways of glucose metabolism under basal conditions appear to be insulin independent.

KW - glucose oxidation

KW - indirect calorimetry

KW - insulin deficiency

KW - Somatostatin

UR - http://www.scopus.com/inward/record.url?scp=0020573546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020573546&partnerID=8YFLogxK

U2 - 10.1007/BF00253195

DO - 10.1007/BF00253195

M3 - Article

C2 - 6139321

AN - SCOPUS:0020573546

VL - 25

SP - 325

EP - 330

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 4

ER -